The invention relates to novel compounds which are both phosphodiesterase 4 (PDE4) enzymeinhibitorsand muscarinic M3 receptor antagonists, methods of preparing such compounds, compositions containing them and therapeutic use thereof.
[EN] HETEROARYL DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES<br/>[FR] DÉRIVÉS HÉTÉROARYLE POUR LE TRAITEMENT DE MALADIES RESPIRATOIRES
申请人:CHIESI FARMA SPA
公开号:WO2015082616A1
公开(公告)日:2015-06-11
The invention relates to novel compounds of formula (I) which are both phosphodiesterase 4 (PDE4) enzyme inhibitors and muscarinic M3 receptor antagonists, methods of preparing such compounds, compositions containing them and therapeutic use thereof.
NITROGEN-CONTAINING FUSED HETEROCYCLIC SHP2 INHIBITOR COMPOUND, PREPARATION METHOD, AND USE
申请人:SHANGHAI RINGENE BIOPHARMA CO., LTD.
公开号:US20220127271A1
公开(公告)日:2022-04-28
Disclosed are a nitrogen-containing fused heterocyclic SHP2 inhibitor compound, a preparation method, and use. The nitrogen-containing fused heterocyclic SHP2 inhibitor compound is represented by formula I below. The compound has high inhibitory activity for an SHP2 enzyme and tumor cell proliferation, and has good druggability.
Traditional phosphorus–nitrogen (P–N) flame-retardant systems for polypropylene (PP) always act through joint action of the gaseous phase and condensed phase, and are accompanied with a decrease of the thermal stability and water resistance. In this work, a novel mono-component and gas-dominated flame retardant, named DPPIP, was prepared through an amidation reaction of diphenylphosphinyl chloride